Resources>Blog>Partner with Biointron: Your CRO Solution for Custom Antibody Development

Partner with Biointron: Your CRO Solution for Custom Antibody Development

Biointron 2024-12-12 Read time: 2 mins

The development of custom antibodies is a critical component in advancing research and therapeutic innovation. Biointron, a Contract Research Organization (CRO) specializing in antibody expression services, provides comprehensive support to biotech companies seeking reliable, high-quality, and large-scale antibody production services. 

Expertise in Antibody Discovery and Expression 

Biointron’s core strength lies in its expertise in the discovery, engineering, and antibody production services of custom antibodies. The company employs advanced platforms for hybridoma development, phage display technology, and recombinant antibody expression to cater to a broad range of applications, including diagnostics, therapeutics, and basic research. 

One of Biointron’s key offerings is Abinvivo, a Biointron brand that provides in vivo antibodies and reagents for research use. Biointron’s catalog products for in vivo research can be found at Abinvivo, where we have a wide range of Benchmark Positive Antibodies, Isotype Negative Antibodies, Anti-Mouse Antibodies, Bispecific Antibodies, and Antibody-Drug Conjugates. 

Related: Abinvivo’s In Vivo Antibody Products: Differences in V3, V6, and V9

Abinvivo also integrates analytical validation as part of our services. This ensures that each batch of antibodies meets the purity, stability, and functional requirements critical for success in downstream applications. 

Supporting Therapeutic Antibody Development

The therapeutic antibody market continues to grow, driven by innovations in immuno-oncology, autoimmune disease therapies, and infectious disease research. Biointron supports these efforts by offering services like humanization of monoclonal antibodies, a key step in transitioning murine-derived antibodies for human clinical applications.

A Trusted Partner for Antibody R&D

Biointron is committed to maintaining transparent communication and collaboration throughout the project lifecycle. Our team of scientists works closely with clients to ensure the antibody development process aligns with project goals, budgets, and timelines.

For biotech firms navigating complex research demands, partnering with Biointron offers a streamlined approach to custom antibody development. Our integrated solutions, technical expertise, and focus on quality provide the support necessary to bring innovative antibody-based products to market.

Recommended Articles
AI Can Design Antibodies. But Where Does the Experimental Data Come From?

Artificial intelligence is quickly becoming part of monoclonal antibody discover……

Aug 17, 2026
Fluorescent VHH Probes for Detection

Explore fluorescent VHH probes for high-resolution detection, cell imaging, and ……

Aug 14, 2026
VHH Antibodies with ELISA Platforms: Applying VHH Antibodies for High-Sensitivity Detection

Discover how VHH antibodies enhance ELISA platforms with high sensitivity, stabi……

Aug 12, 2026
Use of VHHs in Lateral Flow Assays: Improving Rapid Diagnostic Tests with VHH Antibody Technology

Explore how VHH in lateral flow assay development improves rapid diagnostics thr……

Aug 10, 2026

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.